Mediterr J Rheumatol 2017;28(4):217-20
Rituximab and lenalidomide combination treatment for rheumatoid arthritis complicated with myelodysplastic syndrome: A case report
Authors Information

1: Rheumatology Department, 417 Army Share Fund Hospital (NIMTS), Athens, Greece
2: Department of Pathophysiology, General Hospital of Athens “Laiko”, Athens, Greece

Rheumatoid arthritis patients might experience several hematologic complications. The development of myelodysplastic syndrome is not clearly associated with RA, even though it has been described in some patients with pre-existing disease. There are only few data available in the literature concerning the therapeutic approach of such patients. Herein, we report a case of RA complicated with progressive MDS, successfully treated with rituximab and lenalidomide combination therapy.